Loading organizations...
Archimed is a global private equity firm exclusively focused on the healthcare industry. The firm deploys capital and strategic expertise to foster sustainable development across various healthcare sub-sectors. Its investment strategy centers on identifying and supporting companies poised to enhance innovation and contribute positively to global health outcomes.
Founded in 2014, Archimed emerged from the conviction that a specialized investment approach was essential for navigating the complexities and opportunities within the global healthcare market. This insight drove the establishment of a platform dedicated solely to providing tailored financial and strategic support to healthcare businesses.
Archimed partners with growth-oriented healthcare companies, serving as a strategic capital provider and advisor to management teams. Its vision is to accelerate global healthcare innovation and drive the sustainable evolution of the industry. The firm aims to achieve a lasting positive impact through focused investments in pioneering health businesses.
Key people at Archimed Capital.
Archimed Capital was founded in 2014 by Denis Ribon (Partner & Co-founder).
Archimed Capital was founded in 2014 by Denis Ribon (Partner & Co-founder).
Archimed Capital has 1 tracked investment across 1 company. The latest tracked deal is $6.0M Seed in Turtle Club in May 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2025 | Turtle Club | $6.0M Seed | Theia Ventures | Peter PAN, 7percent Ventures, A Capital, Ethereal Ventures, Fmfw.io, ParaFi Capital, Vitalik Buterin, Joseph Lubin, Ryan Fang, Yoann Turpin, Auros, Bodhi Ventures, Chorus ONE, ConsenSys, Frachtis, L2iv, Laser Digital, Moonhill Capital, RE7 Capital, Selini Capital, Shorewoods, Susquehanna, Trident Digital, Triton Liquid Fund, Tulipa Capital |
Key people at Archimed Capital.
